robhood - WHAT is your issue with the contents of Decan's posts?? Your words ring hollow without a little more subsantiation.
Decan points out that there is an established standard for measuring the efficacy of an ovarian cancer therapeutic.
He provides clear references for this information.
He points out, referenced once again, that PRR used a different LOWER standard for reasons unknown.
This is extremely valuable information and Food for Thought.
You find these posts disturbing in some way. WHY????
nothing has changed - all still good with prr, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.5¢ | $251.5K | 806.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 121215 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 2864 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |